Trevena, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Pipeline
    • Overview
    • TRV045
    • TRV250
    • TRV734
  • Products
    • OLINVYK™ (oliceridine) injection
  • Medical Affairs
    • Investigator-Initiated Trials
    • Contact Medical Information
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Info
    • Stock Info
    • Resources
    • Governance
  • Careers
  • Contact
    • Contact Medical Information
    • Whistleblower Hotline

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events & Presentations
    • Presentations
    • IR Calendar
  • Financial Info
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Stock Info
    • Quote
    • Analyst Coverage
    • IRS Form 8937
  • Resources
    • Email Alerts
    • Contacts
    • FAQ
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Governance Documents

Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain

Dec 13, 2021 7:00am EST

Trevena Reports Third Quarter 2021 Results

Nov 15, 2021 7:00am EST

Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team

Nov 11, 2021 7:00am EST

Trevena to Release Third Quarter 2021 Financial Results on November 15th, 2021

Nov 08, 2021 7:00am EST

Trevena Announces Two OLINVYK® Presentations at ANESTHESIOLOGY® 2021

Oct 13, 2021 7:00am EDT

Trevena Announces Results of TRV027 Proof-of-Concept Study in COVID-19 Patients

Sep 30, 2021 7:00am EDT

Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences & MedTech Summit

Sep 17, 2021 7:00am EDT

Trevena to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Sep 09, 2021 7:00am EDT

Trevena Announces Two OLINVYK® Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY® 2021

Aug 30, 2021 7:00am EDT

Trevena Announces Wake Forest Baptist Health Joining OLINVYK® Clinical Outcomes Study

Aug 25, 2021 7:00am EDT
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...31
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2023 Trevena, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Disclaimer Sitemap